Loading investment pitches...
Equity Research Database
Institutional Investment Pitches
Explore thousands of hedge fund pitches, high-conviction equity research memos, and portfolio manager commentary extracted from quarterly letters.
Explore thousands of hedge fund pitches, high-conviction equity research memos, and portfolio manager commentary extracted from quarterly letters.
IRadimed (IRMD): We initiated a position in IRadimed at the start of the quarter, replacing Talkspace (TALK) after it was acquired. We view the...
— Nathan Fredrick, CFA
Full equity research memos, financial breakdowns, and hedge fund thesis write-ups are reserved for BSD Research ($50/mo) and Pro subscribers.
Already a Research or Pro subscriber? Sign In
Other investors who've written on IRadimed Corporation
No other institutional pitches found for this ticker yet.
More institutional theses from Riverwater Partners Small Cap Strategy
AtriCure ($ATRC) specializes in surgical devices for cardiac ablation and left atrial appendage management to treat atrial fibrillation and post-operative pain, representing an average weight of 3.88% during the quarter. The manager maintains...
Red Violet ($RDVT) provides proprietary big-data analytics and identity intelligence solutions through its cloud-based IDI and FOREWARN platforms, accounting for an average 2.59% weighting. The manager is...
PDF Solutions ($PDFS) delivers specialized analytics, software, and intellectual property that optimize manufacturing yields and operational efficiency across the semiconductor supply chain, representing an average weight of 2.53%. The manager remains...